Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine

Worldwide, hepatitis C virus (HCV) is a common infection. Due to new antiviral approaches and the approval of direct-acting antiviral agents (DAA), HCV therapy has become more comfortable. Nevertheless, there are special patient groups, in whom treatment of HCV is still challenging. Due to only few...

Descripción completa

Detalles Bibliográficos
Autores principales: Hüsing, Anna, Kabar, Iyad, Schmidt, Hartmut H., Heinzow, Hauke S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581234/
https://www.ncbi.nlm.nih.gov/pubmed/26251895
http://dx.doi.org/10.3390/ijms160818033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581234/
https://www.ncbi.nlm.nih.gov/pubmed/26251895
http://dx.doi.org/10.3390/ijms160818033

Ejemplares similares